NCT03032549 (NB10) is a NA clinical trial of RTD in Dietary Supplements, sponsored by Texas A&M University.

Who is sponsoring NCT03032549?

NCT03032549 is sponsored by Texas A&M University.

What drugs are being tested in NCT03032549?

Interventions in NCT03032549: RTD, Placebo.

What condition does NCT03032549 study?

NCT03032549 studies Dietary Supplements.

Is NCT03032549 still recruiting?

NCT03032549 is currently completed. Last updated 26 January 2017.

Last reviewed 2017-01-26 · How we verify

NCT03032549: NB10

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Safety of a Ready to Drink Supplement

Completed NA Last updated 26 January 2017

What this trial tests

NA trial testing RTD in Dietary Supplements in 28 participants. Completed in 1 September 2016.

Timeline

1 January 2016

Primary endpoint
1 September 2016

1 September 2016

Quick facts

Lead sponsor	Texas A&M University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	health services research
Enrollment	28
Start date	1 January 2016
Primary completion	1 September 2016
Estimated completion	1 September 2016

Drugs / interventions tested

RTD
Placebo

Conditions studied

Dietary Supplements — all drugs for Dietary Supplements →

Sponsor

Texas A&M University

Who can join

Adults 18 to 40, any sex, with Dietary Supplements. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine a Ready to Drink (RTD) supplement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Short-Term Effects of a Ready-to-Drink Pre-Workout Beverage on Exercise Performance and Recovery.
Collins PB, Earnest CP, Dalton RL, Sowinski RJ, et al · · 2017 · cited 30× · PMID 28763003 · DOI 10.3390/nu9080823

Verify or expand the search:

Other recruiting trials for Dietary Supplements

Currently open trials in the same condition.

NCT06379997 — Oral Supplementation Compared With Hyaluronic Acid Infiltration in Rotator Cuff Tendinopathies · NA · recruiting
NCT06138106 — Developing a Nutritional Supplement to Increase Collagen Synthesis in People · NA · recruiting

Other Texas A&M University trials

Trials by the same sponsor.

NCT07079995 — Healthy School Recognized Campus: A Hybrid Type 2 Implementation-Effectiveness Trial · NA · recruiting
NCT06950775 — The Neighborhood & Health Study · recruiting
NCT06890689 — Effectiveness of Scaling and Root Planing in Deeper Pockets · active not recruiting
NCT06797089 — Does myTAP Oral Appliance Therapy Including a Mouth Shield Lessen Periodontitis in Mouth-Breathers Who Snore? · NA · completed
NCT05959434 — Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and PTSD · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03032549 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Texas A&M University
Last refreshed: 26 January 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing